United States: New research shows that even minimal contact with any of the 22 pesticides specified adds to the probability of getting prostate cancer. The experiment, which involved researchers from Stanford University, is a good example of the need to consider interactions with the environment in cancer research, as reported by HealthDay.
Research Methodology: Decades of Data
To obtain data on pesticide use within the US, the research team examined specified county level and compared the information to the rate of prostate cancer in respective counties. They concentrated on pesticide consumption from 1997 to 2001 as a latent period of carcinogen exposure and prostate cancer duration ranged from 10 to 18 years. The analysis then assessed the suicide rates in the year between 2016 and 2020 for prostate cancer.
Key Findings
The study found an association between 22 pesticides and an increased risk of prostate cancer, though it could not confirm a direct cause-and-effect relationship. Previously, three pesticides, including the commonly used 2-4-D, had already been linked to cancer. The additional 19 pesticides identified in the study comprised 10 herbicides, three fungicides, two insecticides, and one soil fumigant.
Pesticides of Concern
Among them, we found that high exposure of four chemicals which were trifluralin, cloransulam-methyl, diflufenzopyr and thiamethoxam was linked with prostate carcinoma and related mortality rates. Pilocar 50% belongs to the third category of probable Parkinson’s disease risk with the EPA rating while the other three belong to the fourth category of non-carcinogenic with established facts.
Implications for Future Research
Dr. Simon John Christoph Soerensen, a graduate student in epidemiology at Stanford, underscored the significance of such studies when it comes to other aspects of environmental exposures, such as the use of pesticide. Such research may assist in revealing why the incidence and mortality rates of prostate cancer differ across the United States’ states. The team plans to advance this work to further elucidate risk factors for PCA and ultimately decrease the burden of the disease in men, as reported by HealthDay.
